Company news
Virbac SA news in 2025
Virbac SA's news releases, calls and decks from 2025, newest first.
VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm
December 16, 2025
Declaration of the number of shares and voting rights 11/2025
December 8, 2025
Declaration of the number of shares and voting rights 10/2025
November 7, 2025
VIRBAC Announces Third Quarter 2025 Sales
October 16, 2025
Next-generation collar for long-lasting parasite protection in cats and dogs
October 14, 2025
Declaration of the number of shares and voting rights 09/2025
October 3, 2025
Virbac introduces world-first medicated feed for cats
September 24, 2025
Virbac: 2025 Half-year results
September 12, 2025
Declaration of the number of shares and voting rights 08/2025
September 5, 2025
Declaration of the number of shares and voting rights 07/2025
September 5, 2025
Virbac: : Paul Martingell's compensation terms
August 18, 2025
Virbac: in the first half of 2025, revenue recorded solid growth of +5.6% at constant exchange rates and scope of consolidation
July 16, 2025
Declaration of the number of shares and voting rights 06/2025
July 4, 2025
VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effective September 1, 2025
June 19, 2025
Declaration of the number of share and voting rights 05/2025
June 10, 2025
Declaration of the number of shares and voting rights 04/2025
May 7, 2025
Decks in 2025
- H1 2025 Earnings Presentation
Earnings · 29 slides · September 2025
- FY2024 Earnings Presentation
Earnings · 32 slides · Mar 14, 2025